The global Subdermal Contraceptive Implants Market had a valuation of $2.0 billion in 2022, and it is anticipated to reach $4.5 billion by 2032, exhibiting a robust compound annual growth rate (CAGR) of 6.8% during the projected period. The surge in demand for long-term contraceptive solutions among women, as well as an increasing need for population control in developing countries, stands as...